Background Patient‐reported outcomes measures (PROMs) assess a patient's subjective
appraisal of health outcomes from their own perspective. Despite hypothesised benefits that …

Background The routine measurement of patient-reported outcomes in cancer clinical care
using electronic patient-reported outcome measures (ePROMs) is gaining momentum …

Importance Patient-reported outcome measures (PROMs) come directly from the patient,
without clinician interpretation, to provide a patient-centered perspective. Objective To …

Background Electronic patient-reported outcomes (ePROs) are commonly used in oncology
clinical practice and have shown benefits for patients and health resource use. Objective …

Background Research shows that feeding back patient-reported outcome information to
clinicians and/or patients could be associated with improved care processes and patient …

Importance Immune checkpoint inhibitors can produce distinct toxic effects that require
prompt recognition and timely management. Objective To develop a technology-enabled …

Background Electronic prospective surveillance models (ePSMs) for cancer rehabilitation
include routine monitoring of the development of treatment toxicities and impairments via …

PURPOSE Increasing use of immune checkpoint inhibitors (ICIs) in routine cancer care will
increase the incidence of immune-related adverse events (irAEs). Systems are needed to …

Introduction In a randomized controlled trial, we previously investigated if melanoma
patients receiving checkpoint inhibitors had fewer severe immune-related adverse events …

Objective This study aims to investigate the potential benefits of integrating patient-reported
outcomes (PROs) into routine clinical practice for patients undergoing active anticancer …